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SUMMARY: This work investigates the role of oleanolic acid (OA), isolated from the olive (Olea europaea L.) 
leaf, as a radical scavenger and inhibitor of the hydrolyzing enzymes of dietary carbohydrates. New evidence is 
provided showing that OA may capture 2,2’-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) and peroxyl 
radicals, and also exert a strong and non-competitive inhibition of α-glucosidase (IC50 10.11 ± 0.30 µM). The 
kinetic and spectrometric analyses performed indicate that OA interacts with this enzyme inside a hydrophobic 
pocket, through an endothermic and non spontaneous process of a hydrophobic nature. These are two possible 
mechanisms by which OA may facilitate a better control of post-prandial hyperglycaemia and oxidative stress, so 
contributing to preserving insulin signalling. Obesity, insulin resistance and Type 2 Diabetes Mellitus are consid-
ered the first pandemics of the 21st century. In this sense, OA might be used in future preventive and therapeutic 
strategies, as an ingredient in new drugs and functional foods.
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RESUMEN: La Captación de radicales libres y la inhibición de α-glucosidasa, dos posibles mecanismos involu-
crados en la actividad antidiabética del ácido oleanólico. Este trabajo estudia el papel del ácido oleanólico (OA), 
aislado de la hoja de olivo, como secuestrador de radicales libres e inhibidor de enzimas implicados en la hidro-
lisis de los carbohidratos de la dieta, dos mecanismos por los que el triterpeno podría mitigar la hiperglicemia 
postprandial y el estrés oxidativo. Se aportan nuevas evidencias que muestran que el OA puede capturar radi-
cales ácido 2,2’-azino-bis-(3-etilbenzotiazolín)-6-sulfónico y peroxilo, y que ejerce una potente inhibición no-
competitiva de α-glucosidasa (IC50 10.11±0.30 µM). El análisis cinético y espectrométrico llevado a cabo indica 
que OA interacciona con este enzima en el interior de un bolsillo hidrofóbico, mediante un proceso endotér-
mico no espontáneo, de naturaleza hidrofóbica. Estos son dos posibles mecanismos por los cuales el OA puede 
facilitar un mejor control de la hiperglucemia postprandial y el estrés oxidativo, lo que contribuye a preservar la 
señalización de la insulina. La obesidad, la resistencia a la insulina y la diabetes mellitus tipo 2 se consideran la 
primera pandemia del siglo XXI. En este sentido, el OA podría ser utilizado en futuras estrategias preventivas y 
terapéuticas, como ingrediente de nuevos fármacos y alimentos funcionales.
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1. INTRODUCTION
Type 2 Diabetes Mellitus (T2DM), the most 
common form of the disease affecting near 90% 
of diabetic people, is recognized as a redox dis-
order, in which oxidative stress is a primary event 
 underlying insulin resistance, β-cell failure, and long-
term  diabetes complications (Watson, 2014). This 
prompted investigations on the therapeutic use of 
antioxidants, although none of such studies demon-
strated clear effects on the metabolic control of 
diabetic people (Ceriello and Testa, 2009). Another 
strategy to minimize oxidative stress is by reducing 
 glycaemia fluctuations during post-prandial periods, 
since different studies with cells exposed to levels of 
glucose elevated intermittently have demonstrated 
the increased expression of biomarkers for oxida-
tive stress (Quagliaro et al., 2003). An interesting 
approach is the inhibition of enzymes involved in 
carbohydrate breakdown and the intestinal absorp-
tion of glucose. Salivary and pancreatic α-amylases 
(EC 3.2.1.1) cleaves the α-(1→4) bonds of starch 
yielding shorter linear and branched dextrins, which 
are subsequently hydrolyzed at the non-reducing 
end into glucose by α-glucosidase (EC 3.2.1.20) 
in the small-intestinal brush border membrane. 
Synthetic inhibitors, such as acarbose, voglibose or 
miglitol, are widely used in the clinic. However, the 
 appearance of adverse effects is frequent, includ-
ing flatulence, abdominal pain, nausea, vomiting, 
diarrhea, skin hypersensitivity, an elevation in the 
hepatic enzymes and even an increased incidence of 
renal tumors (Fujisawa et al., 2005).
Accordingly, the search for more effective and 
safer natural bio-molecules, with the dual ability 
to decrease glucose absorption and reduce oxida-
tive damage, has become an important scientific 
goal. Oleanolic acid (OA) (3β-hydroxy-olean-12-
en-28-oic acid), a pentacyclic triterpene widely 
distributed in the plant kingdom, has attracted the 
attention of  researchers for its interesting phar-
macological properties (Liu, 2005; Dzubak et al., 
2006), including anti-diabetic activity (Castellano 
et al., 2013). 
The data available nowadays concerning the 
antioxidant activity of  OA are somewhat contra-
dictory. Its ability to react with diverse radical spe-
cies has been evaluated, having obtained an array 
of  varied results (Yin and Chan, 2007; Yang et al., 
2007; Wang et al., 2010; Allouche et al., 2011). The 
OA effect on α-amylase is not completely clear 
(Khati et al., 2013; Wang et al., 2011). However, a 
consensus does exist concerning the efficient inhibi-
tion of  α-glucosidase by the triterpene, and some 
IC50 values in the micro-molar range have been 
reported (Ali et al., 2002; Kang et al., 2012). To 
our knowledge, studies on the mechanism of this 
reaction have not been carried out. Consequently, 
in this work, we investigate the triterpene’s ability 
to scavenge three radical species (ABTS+, DPPH 
and peroxyl), and also to inhibit both α-amylase as 
α-glucosidase. The paper includes a deeper kinetic 
study to determine the type of  inhibition, as well 
as fluorescent measurements to obtain new clues 
about the mechanism of the OA/α-glucosidase 
interaction. This research is part of  a more general 
investigation aimed at exploiting the therapeutic 
potential of  OA against diabetes.
2. MATERIALS AND METHODS
2.1. Plant material, reagents and standards
Olive (Olea europaea L. cv. Picual) leaves were 
hand-picked from adult trees (>10 years old) from 
the experimental olive grove belonging to the 
Instituto de la Grasa-CSIC in Seville. 
All solvents used were of analytical grade. Betulinic 
acid; hexamethyldisilazane; trimethylchlorosilane; 
2,2’-azino-bis(3-ethylbenzothiazoline-6- sulphonic 
acid) (ABTS); 2,2-Diphenyl-1-picrylhydrazyl 
(DPPH); 2,2’-azobis (2-amidinopropane) dihydro-
chloride (AAPH); fluorescein; pancreatic α-amylase; 
potato starch; 3,5-dinitrosalicylic acid; sodium potas-
sium tartrate; α-glucosidase from Saccharomyces cere-
visiae; 4-nitrophenyl-α-D-glucopyranoside (p-NPG); 
and acarbose were purchased from Sigma-Aldrich 
(Sigma-Aldrich Quimica, Madrid, Spain).
2.2. Isolation of oleanolic acid from O. europaea
High purity OA was isolated from olive leaves 
according to the procedure described by us (Guinda 
et al., Patent 2001/2160553). Briefly, dry leaves were 
extracted by maceration with 96% ethanol, which 
was then percolated and subsequently reduced by 
vacuum. Solid OA was obtained by crystallization 
and filtration. Its chemical nature was confirmed 
by GC-MS (P Gutiérrez-Adánez, Thesis of Master, 
University Pablo de Olavide; Seville, 2013), and 
its purity was determined by differential scanning 
calorimetry (DSC) and GC-FID (Albi et al., 2001; 
Guinda et al., 2010).
2.3. Derivatization of oleanolic acid 
The low volatility and high molecular weight of 
OA demands its derivatization prior to the GC anal-
ysis. The silylating reagent was prepared by mixing 3 
mL of hexamethyldisilazane and 1 mL of trimethyl-
chlorosilane with 9 mL of anhydrous pyridine. Ten 
milligrams of OA were dissolved in 20 mL  absolute 
ethanol. An aliquot (100 μL) of this  solution and 
100 μL of 0.5 mg/mL betulinic acid (internal  standard) 
were placed in 1 mL gas-tight vials and evaporated 
to dryness under a N2 stream. The residue was 
 dissolved in 200 μL of the silylating reagent and son-
icated at 70 °C for 15 min. The solution harboring 
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the derivatized triterpene was analyzed by GC-FID 
and GC-MS.
2.4. GC-FID Analysis 
The quantification of OA was carried out by 
a modification of the method described by us in 
(Guinda et al., 2010). Concisely, 1 µL of the silylated 
sample was injected into an Agilent 6890N GC 
(Agilent Technologies, CA), equipped with a Rtx-
65TG Cross-bond capillary column (30 m × 0.25 
mm I.D.; 0.1 mm film thickness) coated with 35% 
dimethyl-65% diphenyl polysiloxane as station-
ary phase (Restek, Co., Bellefonte, PA) and a FID 
detector. The injection was done in the split mode, 
and hydrogen was used as carrier gas (pressure at 
column head 140 kPa). The oven temperature was 
maintained at 260 °C, and the injector and detector 
temperatures at 300 °C.
2.5. GC-MS identification of oleanolic acid
The analysis of derivatized OA was performed 
using a coupled gas chromatograph-mass spectrom-
etry detector (GC-MS) QP2010 Ultra (Shimadzu 
Europa GmbH) fitted with an AOC-20i auto- 
sampler, an ion source of electron impact and a 
quadrupole detector. The splitless mode was used 
and the injector temperature was set at 290 °C. 
Helium was the carrier gas at a pressure of 53.1 kPa 
and a flow of 1 mL/min. The oven temperature 
program was as follow: initial temperature 50 °C 
for 1 min, 50–200 °C at 40 °C/min, 200–280 °C at 
10 °C/min, held at 280 °C for 8.50 min, and finally 
at 300 °C for 1 min. Total run time: 24,25 min. The 
MS conditions were: interface temperature: 280 °C; 
ion source temperature: 220 °C; electron impact: 
70  eV; acquisition mode: scan (m/z 50–600). The 
identification of the OA trimethylsilyl derivative 
was accomplished by comparing the retention time 
and abundance ratio of two fragment ions (203 and 
189 m/z) with those of the standard compound.
2.6. Purity evaluation by DSC
The OA purity was also assessed by Differential 
Scanning Calorimetry (DSC), following the method 
described in (Albi et al., 2001). A TA-Q2000 calorime-
ter equipped with a cooling unit (Thermal Analysis 
Instruments; Barcelona, Spain) was used. This 
instrument was calibrated with indium (99.9 %). The 
OA samples (10–15 mg) were enclosed in hermeti-
cally sealed aluminum pans and analyzed against air 
(empty pans) as reference. The calorimeter chamber 
was previously thermostatized at 30 °C for 10 min. 
Then, the melting curves from 30 to 350 °C (heat-
ing rate 10 °C/min) were recorded. The data were 
analyzed using the Peak Program software of the 
TA-Q2000.
2.7. Radical scavenging
2.7.1. 2,2’-azino-bis(3-ethylbenzothiazoline-6-
sulphonic acid) (ABTS) assay
The ABTS+ scavenging capacity was evaluated 
following a modification of the procedure by Re 
et al. (1999). The radicals were generated by oxidiz-
ing its precursor ABTS (7.0 mM in methanol) with 
potassium persulfate (2.45 mM), maintaining the 
mixture overnight in the dark at room temperature. 
The resultant ABTS+ solution was diluted to have 
an absorbance at 734 nm in the range of 0.7–0.8. 
An aliquot (10 µL) of OA samples (0.5, 1.0, 4.0 and 
10.0 mM in methanol), or a blank (methanol), was 
added to 1 mL of the ABTS+ solution. The mix-
ture was stirred and left to react in the dark at room 
temperature for 5 min, and then the absorbance at 
734 nm was recorded in a Beckman DU 640 UV-VIS 
light spectrophotometer (Beckman Coulter Inc.; 
Pasadena, CA; USA). The results were expressed as 
percentage of the initial absorbance of the ABTS+ 
solution. Butylated hydroxytoluene (BHT) (0.5 mM 
in methanol) was assayed as reference antioxidant.
2.7.2. 2,2-Diphenyl-1-picrylhydrazyl (DPPH) free 
radical scavenging test 
The OA ability to capture DPPH radicals was 
also assessed spectrophotometrically according to 
the revised protocol by Sharma and Bhat (2009). 
The reaction mixture (4 mL), containing 50 µM 
DPPH alone or in the presence of OA (1, 25, 50, 100 
and 1000 µM), was incubated for 30 min at 30 °C in 
the dark, and then the absorbance at 517 nm was 
measured using the Beckman DU 640 spectropho-
tometer. The scavenging activity was expressed as 
percentage of the initial absorbance of the DPPH 
solution. BHT (50 and 100 µM) was also included in 
the assay as a positive control. 
2.7.3. Oxygen Radical Absorbance Capacity 
(ORAC) Assay 
The ORAC assay was performed following a 
modification of the procedure reported by Prior et al. 
(2003), in which fluorescein was the target of the 
peroxyls generated with 2,2’-azobis (2-amidinopro-
pane) dihydrochloride (AAPH). An aliquot (20 µL) 
of the OA sample [0.1–0.7 mM in 10% DMSO (in 
75 mM phosphate buffer, pH 7.4 at 37 °C)] or a blank 
(buffered DMSO) was pre-incubated with 120  µL 
of 116.7 nM fluorescein for 10 min at 37 °C. Then, 
the reaction was started by the addition of 60 μL of 
40 mM AAPH. The time course of the fluorescent 
decay (λex = 485 nm, λem = 525 nm) was recorded for 
80 min using a Fluostar Galaxy plate reader (BMG 
Labtechnologies, Offenburg, Germany). The capac-
ity to scavenge peroxyl radicals correlates with the 
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net area under the fluorescent decay curve (AUC), 
calculated by subtracting the OA sample AUC from 
the blank AUC. The AUCs were automatically cal-
culated by the Fluostar software. The ORAC value 
(expressed as the μmol Trolox equivalent), was 
 determined from the calibration curve obtained with 
standard Trolox in the concentration range 1–10 µM.
2.7.4. Rancimat method
 Rancimat 743 equipment (Metrohm AG; Erisau, 
Switzerland) was used for evaluating the role of 
OA against lipid peroxidation. An aliquot (300 µL) 
of OA solutions (0.5 and 1.0 mM in DMSO) was 
added to 3.0 g of olive or sunflower oil. The mixture 
was heated at 100 °C whereas an air flow (20 L/h) 
bubbled constantly. The effluent gas was collected in 
de-ionized water, whose electrical conductivity was 
continuously monitored. In this system, the antioxi-
dant activity correlates with the extension of timing 
up to the inflection point in the conductivity curve 
(induction time) (Burkow et al., 1995). The antioxi-
dant activity index (AAI) was calculated from the 
ratio induction time of the oil with OA/induction time 
of oil alone. BHT (250 and 500 µg/g) was likewise 
included in the assays as a reference antioxidant.
2.8. In vitro inhibition of carbohydrate 
hydrolyzing enzymes
2.8.1. In vitro assay for α-amylase
α-Amylase was assayed using the chromo-
genic method adopted by Sigma–Aldrich (www. 
sigmaaldrich.com/technical-documents/protocols/ 
biology/enzymatic-assay-of-a-amylase.html). 
Porcine pancreatic α-amylase was dissolved in an 
ice-cold 20 mM sodium phosphate buffer (pH 6.9 at 
37 °C) containing 6.7 mM NaCl. The potato starch 
solution (1% w/v) was prepared in the same buffer. 
In a first series of experiments, 40 µL of OA solu-
tions (5–1000 µM in buffered 10% DMSO), 60 µL 
of phosphate buffer, and 400 µL of the substrate 
solution were mixed in a screw-top glass tube, and 
pre-incubated at 37 °C for 5 min. The reaction was 
subsequently started by the addition of 200 µL of the 
enzyme solution (1 unit/mL), and the mixture was 
incubated at the same temperature for 5 min. Then, 
350 µL of the DNS color reagent (96 mM 3,5-dini-
trosalicylic acid, 5.31 M sodium potassium tartrate 
in 2 M NaOH) were added to the tube and placed 
into a 85 °C water bath for 15 min. Then, the mix-
ture was removed and diluted with 3 mL distilled 
water. The maltose generated in the reaction (absor-
bance at 540 nm) was quantified from the calibration 
curve obtained with standard maltose in the range 
of 50 µM–3.75 mM (A540 = 2.6185 ∙ 10
–4 [maltose] – 
0.0279; r2 = 0.9972). Control incubations representing 
100% enzyme activity were conducted in an identical 
fashion, replacing the OA solution by DMSO. Blank 
incubations, where the enzyme solution was replaced 
with phosphate buffer, were also included. In a second 
series of assays, the enzyme was pre-incubated with 
OA at 37 °C, and the reaction was started by the addi-
tion of the starch solution. In both series, acarbose 
(20 µM) was introduced as a reference inhibitor.
2.8.2. In vitro assay for α-glucosidase
The α-glucosidase activity was tested by adapting 
the protocol by Kang et al. (2011) to 96-well micro-
plates. To each well, 30 µL of a 100 mM phosphate 
buffer containing 100 mM NaCl (pH 6.8 at 37 °C), 
30 µL of 2.5 mM p-NPG in this same  buffer, and 
30 µL of OA (0.05–50.0 µM in buffered 10% DMSO), 
were added. The plate was pre-incubated at 37 °C 
for 5 min, and the reaction was started by add-
ing 30 µL of the α-glucosidase solution (0.2 U/mL 
α-glucosidase in phosphate buffer). After 20 min at 
the same temperature, 120 µL of 100 mM sodium 
carbonate were added to stop the reaction. The 
release of 4-nitrophenol (ε = 18.3 mM–1 cm–1) was 
determined by measuring the absorbance at 405 nm 
in a Multiskan Spectrum (Thermo Labsystems; 
Milford, MA, USA) micro-plate reader. One enzyme 
activity unit is defined by the release of 1.0 µmol 
α-D-glucopyranoside per minute at 37 °C. Control 
incubations representing 100% enzyme activity were 
conducted, replacing OA solutions with DMSO. 
Likewise, blank incubations were carried out where 
the enzyme solution was replaced by the phosphate 
buffer. The inhibitory activity of OA was assayed in 
the range of 0.05–50.0 µM, and 20 µM acarbose was 
introduced as reference inhibitor. 
2.8.3. Fluorescence quenching measurements 
In these experiments, α-glucosidase was assayed 
at 1 µM in the presence of OA (0–25 µM). The reac-
tion mixture (whose final volume was brought to 
4.0 mL with phosphate buffer) was incubated for 10 
min at 20, 30 and 37 °C. The fluorescent spectra of 
α-glucosidase were obtained on a Cary Eclipse fluo-
rescence spectrophotometer (Agilent Technologies; 
Santa Clara, CA, USA) equipped with a 10.0 mm 
quartz cell and a thermo-stated bath. The excitation 
wavelength was 280 nm, and the emission spectra 
were recorded from 300 to 500 nm. The excitation 
and emission bandwidths were both set at 5 nm. 
Appropriate blanks corresponding to the phosphate 
buffer alone were assayed and subtracted to correct 
background fluorescence. 
2.9. Statistical analysis
All data are presented as the means ± standard 
deviation (SD) from a series of three independent 
experiments carried out with five replicates. The 
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data were evaluated by a one-way ANOVA with the 
SigmaPlot 12.5 software (SPSS, Inc., Chicago, IL), 
and the differences between means were assessed 
using the Duncan’s multiple-range test. Statistical 
significance was considered at p < 0.05.
3. RESULTS
3.1. Obtaining pure oleanolic acid from olive leaf 
title One
Eighteen grams and six hundred thirty two mil-
ligrams of crystallized OA were obtained from one 
kilogram of dried olive leaves. Its purity (98.6%) 
was determined by both GC-FID and DSC (data 
not shown).
3.2. Free radical scavenging
3.2.1. 2,2’-azino-bis(3-ethylbenzothiazoline-6-
sulphonic acid) (ABTS+) assay 
The stable radical ABTS+ is commonly used 
for the estimation of total antioxidant capacity. 
The simpler and more frequently applied approach 
of this assay consists of analyzing the activity of 
a sample against pre-formed radicals. With this 
scheme, we have found that OA is a moderate scav-
enger of ABTS+, and its action is dose-dependent 
(Table 1). Thus, 10 mM OA removed 24% of the 
initially present ABTS+. In comparison, 0.5 mM 
BHT abolished these radicals almost completely. On 
the other hand, we have tested two other solvents 
in addition to methanol, for preparing the OA solu-
tions: carboxymethylcellulose (CMC) and DMSO, 
but they did not improve the scavenging activity of 
the triterpene. 
3.2.2. 2,2-Diphenyl-1-picrylhydrazyl (DPPH) free 
radical scavenging test 
DPPH is also very common for the study of nat-
ural antioxidants. Its solutions have a characteristic 
deep purple color (λmax 515–517 nm) that decolor-
ize by the action of radical scavengers. Performing 
this procedure, it became evident that OA does not 
capture DPPH radicals, at least at concentrations 
lower than 1 mM (data not shown). The use of 
DMSO substituting for methanol as the triterpene 
solvent did not provide better results. 
3.2.3. Oxygen Radical Absorbance Capacity 
(ORAC) Assay 
The ORAC assay determines the ability of a com-
pound to preserve fluorescein from the attack of 
peroxyls generated with AAPH. Using this method, 
OA showed a low and dose-dependent capability to 
react with these radicals (Figure 1). The net areas 
under the fluorescent decay curves were linearly fit-
ted to the OA concentrations in the range of 0.1–0.7 
mM. An ORAC value of 1.628 nmol Trolox equiv/
µmol OA was determined from the calibration curve 
obtained with standard Trolox (Net AUC = 19.904 
nmol Trolox + 6.335; r2 = 0.9899). 
3.2.4. Rancimat method 
The Rancimat method, based on the induction of 
lipid oxidation by exposure to airflow at high tem-
peratures, is likely the most commonly used proce-
dure for measuring the oxidative stability of oils and 
fats. The process occurs via a chain reaction (with 
participation of hydroxyl and peroxyl radicals), in 
which the double bonds of unsaturated fatty acids 
undergo cleavage, releasing volatile short-chain 
organic acids, aldehydes and ketones. The reaction 
is characterized by a relatively slow initial period 
before it suddenly speeds up. The time for this to 
happen, called induction time, is taken as an indi-
cation of the oxidative stability of the lipid sample. 
The Rancimat procedure can be also applied for 
assessing the efficiency of antioxidants, by apprais-
ing how long they are able to prolong the initial 
induction step. This paper reports the use of such 
equipment for evaluating the antioxidant potential 
of OA for the first time. 
We first ran experiments with an olive oil, chosen 
by its low content in minor components. In this lipid 
system, 0.5 mM OA did not prevent oil oxidation, 
but instead it exerted a slight pro-oxidant activity, as 
Table 1. Scavenging of the ABTS+ radical by oleanolic 
acid. Results are expressed as the means ± SD (n = 15). 
CMC = carboxymethylcellulose [2.5% (w/w)]. BHT was 
included in the assay as positive control. Different letters 
within a column indicate that values are different at p<0.05
absorbance 
(λ734) reduction (%)
ABTS+ 0.779 ± 0.041a
+ OA (mM) in methanol
0.5 0.682 ± 0.035b,d 12.5 ± 0.6
1.0 0.676 ± 0.038b,d 13.2 ± 0.7
4.0 0.645 ± 0.047b,e 17.2 ± 1.2
10.0 0.586 ± 0.030c,h 24.8 ± 1.3
+ OA (mM) in CMC
0.5 0.691 ± 0.054d 11.2 ± 0.9
1.0 0.673 ± 0.034b,d,f 13.5 ± 0.7
4.0 0.636 ± 0.032e,f,h 18.4 ± 0.9
+ OA (mM) in DMSO
4.0 0.631 ± 0.028e,g,h 18.9 ± 0.9
10.0 0.599 ± 0.031h 23.2 ± 1.2
+ BHT 0.5 mM 0.026 ± 0.002i 96.7 ± 3.5
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evidenced by the shortening of the induction period 
(Figure 2). By doubling the OA concentration in 
the medium no significant changes were observed. 
A second sequence of trials was performed with 
refined sunflower oil, whose triglycerides are richer 
in polyunsaturated fatty acids than those of olive 
oil. In that lipid matrix, the triterpene showed a clear 
and dose-dependent pro-oxidant action. So, in the 
presence of 1.0 mM OA the oxidative stability of 
the sunflower oil fell by 50%. In both experimental 
series, BHT was able to remarkably delay oil oxida-
tion. To the best of our knowledge, this is the first 
time a pro-oxidant action of OA is reported. 
3.3. Inhibition of carbohydrate hydrolyzing enzymes
3.3.1. Effect of OA on the pancreatic α-amylase 
α-Amylase activity was assayed using potato 
starch as substrate to determine the maltose pro-
duced in the reaction. We performed two series of 
experiments, considering whether starch and OA 
were first pre-incubated and the reaction was started 
by the addition of the enzyme solution; or whether 
the enzyme was first pre-incubated with the triter-
pene and then the reaction initiated by addition of 
the substrate. With both approaches, no enzyme 
inhibition was observed in the OA concentration 
range 5.0 µM–1.0 mM. However, 20 µM acarbose 
(the reference inhibitor) was able to repress the 
enzyme activity by 27.2 and 30.1%, respectively 
(data not shown). 
3.3.2. Inhibition of the α-glucosidase activity by OA 
Unlike α-amylase, OA caused a strong inhibi-
tion of the α-glucosidase activity. This effect was 
dose-dependent, with the enzyme activity decreas-
ing remarkably when the OA dose augmented 
(Figure 3). In fact, the α-glucosidase action was vir-
tually abolished at 20 µM OA and above. The dose 
resulting in 50% inhibition (IC50) was estimated to 
be 10.11 ± 0.30 µM. 
Figure 1. Oxygen radical absorbance capacity (ORAC) 
assay for OA. Net area under the fluorescent decay curve in 
the presence of increasing concentrations of OA. The inset is 
the calibration curve obtained with standard Trolox. Results 
are expressed as mean ± SD of three independent experiments 
carried out with five replicates.
Figure 2. Effect of OA on the oxidative stability of olive 
and sunflower oils (Rancimat method). Typical conductivity 
vs time curves representative of three independent 
experiments performed with five replicates.
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For a deeper study of the inhibition mechanism 
we first corroborated that α-glucosidase catalysis 
followed a Michaelis-Menten kinetic. The reac-
tion proceeded at its maximum rate (26.84 µmol 
p-NP min–1 mg prot–1) with substrate concentra-
tions greater than 150 µM, and a Km value of 51.34 
µM was determined for p-NPG. We also studied 
the time-course of the reaction in the absence and 
presence of OA (5, 15 and 25 µM), finding that the 
activity vs time relationship progressed linearly for 
at least 25 min (data not shown). Then, we evaluated 
the enzyme activity at increasing concentrations of 
p-NPG, in the presence of different doses of OA. 
The Lineweaver-Burk’s kinetic analysis of results 
indicated that OA was a non-competitive inhibitor 
of α-glucosidase (Figure 4). The inhibition constant 
(Ki) of 9.12 ± 0.24 µM was calculated by both the 
Dixon and Cornish-Bowden analyses.
3.3.3. Fluorescence quenching of α-glucosidase by 
oleanolic acid 
The powerful inhibition that OA exerts on 
α-glucosidase suggests that the triterpene directly 
binds to the protein. To achieve new evidence for 
this interaction, we conducted, for the first time to 
our knowledge, binding studies employing fluores-
cent spectroscopy. The spectra of α-glucosidase in 
the presence of different OA concentrations were 
recorded at 20, 30 and 37 °C (Figure 5). Under the 
same experimental conditions, OA did not display 
intrinsic fluorescence or UV-VIS absorption in 
the wavelength range 300–500 nm, not interfering 
with the α-glucosidase spectra (data not shown). 
α-Glucosidase exhibited a strong fluorescent 
 emission peak at 333 nm after excitation at 280 nm, 
indicating that tryptophans located in inner regions 
of the protein are practically the only ones emitting 
fluorescence. In the presence of OA, significant and 
dose-dependent decreases in the fluorescent inten-
sity were observed. This quenching effect did not 
involve hypsochromic or bathochromic shifts, which 
reveals that the OA/α-glucosidase interaction only 
affected those tryptophyls positioned within a cleft 
of the enzyme. 
Figure 6 shows the Stern-Volmer plots (F0/F = 
1 + KSV[OA]) for the quenching of α-glucosidase 
fluorescence by OA. In this equation, F0 and F 
denote the steady-state fluorescent intensities in the 
absence and presence of the triterpene, respectively; 
and KSV is the Stern-Volmer quenching constant, 
a measure of the interaction strength between the 
protein and its ligand. The plot’s linearity illustrates 
that within the assayed concentration range, a single 
class of enzyme fluorophores is affected by OA. The 
results also show that the KSV values increased with 
increasing temperature, suggesting that quenching 
proceeded mainly through a dynamic mechanism of 
collisions between OA and tryptophans. This rela-
tionship may also be described by the equation log 
[(Fo- F)/ F] = log KA+ n log [Q] (Yan et al., 2014), 
where KA is the binding constant, and n the number 
of binding sites on the protein (Figure 6). It can be 
observed that both KA and n rose with the increase 
in temperature, showing again that the OA/α-
glucosidase interaction was favored under warmer 
conditions. Moreover, the values of n show a trend 
to one, supporting the existence of a single class of 
binding site for OA.
More information about this interaction may 
be inferred from the signs of the thermodynamic 
parameters in the process. The changes in enthalpy 
(ΔH) and entropy (ΔS) can be determined from 
the Van’t Hoff equation [ln KSV = - (ΔH/RT) + 
(ΔS/R); where R is the gas constant], and the free 
energy changes (ΔG) can be estimated from the 
Figure 3. Inhibitory effect of OA on the α-glucosidase 
activity. In the inset the OA dose resulting in 50% inhibition 
(IC50) is expressed. Results are expressed as mean ± SD of 
three independent experiments carried out with five replicates.
Figure 4. Lineweaver-Burk plots for the α-glucosidase 
inhibition by OA.
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ΔG=ΔH–TΔS relationship. Both ΔH and ΔS were 
positive,  proposing that the OA/α-glucosidase 
 association has a hydrophobic nature. Likewise, 
ΔG  values were positive, signifying that the triter-
pene/protein association is endergonic in the assayed 
temperature range (20–37 °C).
4. DISCUSSION
The experimental and clinical evidence indicates 
an inverse association between insulin sensitivity 
and oxidative stress, up to the point that diabetes 
is acknowledged as a phenotype of dysfunctions 
in mitochondria and endoplasmic reticulum, asso-
ciated with an excessive ROS production or an 
impairment of the endogenous antioxidant system 
(Lowell and Shulman, 2005). Because post-prandial 
Figure 5. Fluorescent emission spectra (300–500 nm) of 
α-glucosidase at 20, 30 and 37 °C, in the presence of increasing 
concentrations of OA (λex = 280 nm).
Figure 6. Stern-Volmer plots for the fluorescence 
quenching of α-glucosidase by OA.
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hyperglycaemia induces oxidative stress, the search 
for natural bio-molecules with the dual ability to 
decrease glucose absorption and oxidative damage 
has become an important research topic. Within 
that scenario, this paper reports new findings about 
OA as a radical scavenger and inhibitor of the 
α-glucosidase activity. 
The antioxidant power of OA is subject to con-
troversy since it is markedly influenced by the sin-
gularities of the experimental systems employed in 
its evaluation. We have evaluated the OA ability to 
scavenge three radical species (ABTS+, DPPH and 
peroxyl), finding that it can capture ABTS+ radi-
cals in a moderate and dose-dependent manner, but 
it lacks the ability to scavenge DPPH species. These 
results are in agreement with those previously pro-
vided by other authors (Yang et al., 2007; Wang 
et al., 2010; Allouche et al., 2011). 
The role of  triterpene against peroxyls deserves 
a more detailed discussion. The ORAC assay has 
demonstrated that OA moderately captures the rad-
icals generated from AAPH, although it failed with 
those formed from complex lipid matrixes in the 
Rancimat procedure. In fact, this last protocol has 
revealed that OA might exert a pro-oxidant action. 
These results do not coincide with those of  Yin and 
Chan (2007), who have studied the triterpene poten-
tial for reducing peroxyl radicals using a modified 
TBARS assay on liposomes. They determined that 
OA had a high and dose-dependent activity when 
liposome peroxidation was induced by AAPH and 
2,2’-azobis-(2,4-dimethylvaleronitrile). Closer to 
the Rancimat method, Assimopoulou et al. (2005) 
investigated the OA effect on the oxidation of lard 
and sunflower oil in an oven at 65 °C. They moni-
tored the evolution of peroxide value, reporting 
that OA did not exhibit a clear antioxidant activ-
ity. Wang et al. (2010) examined the effect of  OA in 
liver microsomes of  Sprague-Dawley rats, compar-
ing the triterpene action with those of  well-known 
antioxidants, and found that the protection offered 
by OA against peroxyls depended on the substance 
used for inducing lipid peroxidation. This study 
also evidenced that some molecules recognized as 
antioxidants (vitamin C or α-lipoic acid) could act 
as pro-oxidants depending of the nature of  the lipid 
oxidizing agent. Once again, different experimental 
approaches lead to different conclusions, many of 
which are conflicting. 
Another mechanism by which OA may contrib-
ute to controlling oxidative stress is by decreasing 
post-prandial hyperglycaemia, through the inhibi-
tion of carbohydrate-hydrolyzing enzymes. In this 
paper, we present results proving that OA is not an 
α-amylase inhibitor. This finding is in agreement 
with other published data (Hou et al., 2009; Wang 
et al., 2011) although there are also contradictory 
results supporting that OA might effectively repress 
this activity (Khati et al., 2013; Ali et al., 2006; 
Komaki et al., 2003), with quite variable IC50 values 
in the range of 10 µM–2.6 mM. 
 Unlike α-amylase, OA exerts a strong and dose-
dependent inhibition of α-glucosidase. We have deter-
mined an IC50 10.11 ± 0.30 µM, a very similar value 
to those reported by other authors (Ali et al., 2002; 
Hou et al., 2009; Kang et al., 2012). In addition, we 
present here new contributions to the understanding 
of the OA/α-glucosidase interaction, performing a 
deeper kinetic study and fluorescent measurements. 
We found that OA is a non-competitive inhibitor of 
α-glucosidase (Ki = 9.12 ± 0.24 µM), which binds 
the enzyme in a neighboring region of the active 
site. The comparison of the inhibitory efficiency of 
OA with those of other natural and synthetic struc-
tural analogs allows us to outline some molecular 
features with impact on inhibition: a) the relevancy 
of the hydrophobic skeleton with a hydroxyl group 
in C3 and a carboxyl group in C28 is acknowledged; 
b) the introduction of a second phenolic hydroxyl at 
C2, as in maslinic or corosolic acids, might increase 
the inhibitory power of the triterpene (Ali et al., 
2006); c) the substitution of the methyl at C23 by 
a more bulky ligand (an acetyl group, for example) 
would diminish this ability (Ali et al., 2002); and 
d) the β-orientation of the phenolic hydroxyl in C3 
seems to be clearly influential for the inhibition, 
since corosolic acid with a β-oriented hydroxyl such 
as OA exhibits an IC50 value of 7.47 µM45, whereas 
3-epi-corosolic acid, its α-stereoisomer, displays a 
IC50 63.9 µM (Chowdhury et al., 2014). 
The fluorescent measurements of the OA/α-
glucosidase complex provide useful information 
about the binding mechanism and binding site. The 
intrinsic fluorescence of a folded protein is the result 
of that emitted by its individual aromatic residues, 
with most of the emissions due to the excitation of 
tryptophans and few due to tyrosines and phenyl-
alanines. On the other hand, tryptophans located in 
inner regions of proteins with hydrophobic micro-
environments emit maximum fluorescence near 331 
nm, whereas those residues located on the protein 
surface exposed to a high-polarity aqueous media 
emit at longer wavelengths (≈ 350 nm) (Lacovicz, 
2006). Therefore, the wavelength of maximum emis-
sion can be interpreted in terms of the ratio between 
these two classes of tryptophans. Moreover, intrinsic 
fluorescence often decreases when a protein interacts 
with another compound. The process (quenching) 
happens during the excited state lifetime (collisional 
or dynamic quenching) or due to the formation of a 
complex in the ground state (static quenching).
In our case, the maximum fluorescence emitted 
by α-glucosidase as well as quenching by interac-
tion with OA are detected at 333 nm, indicating that 
the tryptophyls involved in the triterpene binding 
are almost exclusively located inside a hydrophobic 
pocket. The Stern-Volmer plots determined a sin-
gle class of  binding site on α-glucosidase (n tending 
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towards 1), with all the participating tryptophans 
identically accessible (linearity of  the plots within 
the experimental range of  OA concentrations). We 
have also found that the α-glucosidase/triterpene 
interaction responds to a collisional mechanism 
which is favored at warmer temperatures, such as 
that operating in the human body (rising values 
of  quenching constant at increasing temperature). 
The study of  thermodynamic parameters corrobo-
rated the idea that inhibition of  α-glucosidase by 
OA is an endothermic and entropy-driven, a non-
spontaneous process of  predominant hydropho-
bic nature. However, complementary contribution 
of  hydrogen bridges cannot be ruled out because 
the reaction medium is aqueous and both OA 
and α-glucosidase molecules include  prominent 
hydroxyl groups. These outcomes are coherent 
with reported data postulating the existence of 
tryptophans neighboring the α-glucosidase active 
site, which are likely to be more relevant for main-
taining an efficient substrate accommodation 
rather than for the catalysis itself  (Faridmoayer 
and Scaman, 2005). So, the OA binding to these 
tryptophyls would alter the folding of  the protein, 
hindering the access of  the substrate to the inner 
cleft with the active site.
In addition to studies on the inhibition of amy-
lase and glucosidase activities, in recent years new 
data have been reported showing that OA can 
also repress the expression of these proteins in the 
small  intestine (Gabás-Rivera et al., 2013; Khathi 
et al., 2013), in addition to the glucose transporters 
SGLT1 and GLUT2, involved in the absorption of 
the saccharide from the lumen of the small intestine 
to the bloodstream.
In summary, our results support the hypoth-
esis that OA may facilitate a better control of 
 postprandial hyperglycaemia and oxidative stress, 
so contributing to the preservation of  insu-
lin signalling. While its aptitude for inhibiting 
α-glucosidase is powerful, its ability for acting 
as scavenger of   radical species is only moderate. 
This last aspect indicates that the efficient antioxi-
dant activity exhibited by OA in cell cultures and 
experimental animals is likely to result from a more 
intricate and multi- factorial mechanism. In recent 
years, there have been increasing evidence to sup-
port the assertion that OA reinforces the cellular 
antioxidant response by modulating the expres-
sion of  key genes, including antioxidant  proteins 
and NADPH-producing enzymes, responsible for 
maintaining the GSH level and its transportation 
into mitochondria. In this nutri genomic effect of 
OA, the activation of  the nuclear factor erythroid 2 
p45-related factor 2 (Nrf2) seems to play a protago-
nist role (Wang et al., 2010; Castellano et al., 2013).
Obesity, insulin resistance and T2DM are con-
sidered the first pandemics of the 21st century. 
Therefore, National Health Systems are obliged to 
introduce urgent measures which delay or avoid their 
progression. In this sense, OA might be used in future 
preventive and therapeutic strategies. Despite the 
limited number of studies in humans, it is accepted 
that OA is a safe phytochemical. None of these trials 
have recorded significant adverse effects (Xu, 1980; 
Minich et al., 2007; Song et al., 2006; Chen et al., 
2010; Rada et al., 2015). Nevertheless, further inves-
tigations in humans will be necessary to extend the 
use of OA in the design of new drugs and functional 
foods, which allow for personalized diets and nutri-
genomic approaches for the prevention of high-prev-
alence chronic disorders such as diabetes.
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